Latest Breaking News On - ஹார்வர்ட் வணிக பள்ளி வேலை - Page 1 : comparemela.com

What Does December s Drug-Approval Dash Mean for COVID-19 Vaccines? What Does December s Drug-Approval Dash Mean for COVID-19 Vaccines? by Danielle Kost 14 Dec 2020|by Danielle Kost Even in the best of times, pharmaceutical regulators tend to rush through drug applications in December. Now add in a ruthless pandemic. Research and insights from Lauren Cohen. Pharmaceutical regulators around the world tend to speed through drug applications in December and before major national holidays, according to new research that might raise questions about COVID-19 vaccines and other treatments under review. A study by Lauren H. Cohen, the L.E. Simmons Professor of Business Administration at Harvard Business School, finds that 19 percent of all drugs approved worldwide are reviewed in December, twice the percentage of a typical month. However, drugs passed before an informal “desk-clearing” deadline, such as right before a major holiday, are

Lauren cohenDanielle liLaurenh cohenDanielle kostMassachusetts institute of technologyDrug administrationHarvard business school working knowledgeBusiness administrationHarvard business schoolDallas professor umit gurunMassachusetts instituteInternal deadlinesDrug approvalsSafety programsNational bureauEconomic research